China Firms Eye Alliances, Global Markets To Become ‘Next Takeda’

Alliances and expansion into international markets, helped by M&A, are seen by many growing and research-focused Chinese pharma companies as essential to their business development aspirations, although a recent industry forum in Changzhou also heard that such firms should keep a firm footing at home to become an attractive partner.